Harfst & Associates, Inc. Quest Diagnostics Inc Transaction History

Harfst & Associates, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$127.07 - $145.39 $350,586 - $401,131	-2,759 Reduced 50.74%	2,679 $356,000
Q1 2022 Apr 28, 2022	BUY	$129.09 - $164.35 $90,492 - $115,209	701 Added 14.8%	5,438 $744,000
Q4 2021 Feb 07, 2022	SELL	$140.36 - $173.01 $52,073 - $64,186	-371 Reduced 7.26%	4,737 $819,000
Q3 2021 Oct 28, 2021	SELL	$132.95 - $158.0 $75,648 - $89,902	-569 Reduced 10.02%	5,108 $742,000
Q2 2021 Aug 11, 2021	SELL	$126.66 - $141.48 $24,318 - $27,164	-192 Reduced 3.27%	5,677 $749,000
Q1 2021 May 10, 2021	BUY	$114.63 - $133.34 $672,763 - $782,572	5,869 New	5,869 $753,000

925

95.1M

379K

354K

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Harfst & Associates, Inc. with notifications on news.